LEXX - Lexaria Bioscience Corp Net earnings per share (EPS TTM)

Symbol and logo of brand Lexaria Bioscience Corp (LEXX)

The rolling earnings per share trend helps assess the implementation of DehydraTECH, which automates molecular bioavailability to reduce manual labor. Lexaria Bioscience (LEXX) is currently seeking a global partner for patent licensing, while its technology accelerates substance absorption, thereby reducing drug dosages. The value of -5.33 expresses the metric level, allowing investors to analyze the actual financial condition of Lexaria Bioscience without market dogmas.

LEXX (Lexaria Bioscience) Net earnings per one share for the last twelve months history from 07/04/2022 to 11/10/2026

Lexaria Bioscience Corp - analytical breakdowns and key metrics (LEXX)

- share price and expert price forecast:
Stock Quotes Lexaria|LEXX - Analyst Forecast Prices
- market capitalization statistics:
Market Capitalization Lexaria Bioscience Corp.|LEXX - Value Adjusted for Debt and Cash
- business book valuation details:
Book Value per Share Lexaria Bioscience|LEXX - Total Stockholders' Equity|Market Value to Book Value Ratio lexariabioscience.com|LEXX - Aggregate Asset Value
- debt obligations and liquidity statistics:
Debt to Equity Lexaria Bioscience|LEXX - Long-Term Debt to Equity|Short-Term Debt to Capital Lexaria|LEXX - Company Cumulative Debt|Debt to Book Value Lexaria Bioscience Corp.|LEXX - Company Long-Term Indebtedness|Company Short-Term Debts Lexaria Bioscience|Quick Liquidity lexariabioscience.com
- net income and valuation multiples indicators:
LEXX - Final Profit|Projected Future Earnings Lexaria Bioscience|LEXX - Business Payback Period|Forward P/E Multiple Lexaria|LEXX - PEG Multiple|Enterprise Value to EBITDA Ratio Lexaria Bioscience Corp.|LEXX - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Lexaria Bioscience|LEXX - Earnings per share for the last twelve months|Quarterly EPS earnings growth lexariabioscience.com|LEXX - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Lexaria Bioscience
Basic company analysis:lexariabioscience.com - LEXX
Mass-produced product of Lexaria Bioscience Corp

The development of DehydraTECH technology to optimize drug bioavailability requires significant R&D investments for Lexaria Bioscience (LEXX). The fundamental EPS TTM metric aggregates net income over the last four quarters, allocating it per share. This metric allows investors to isolate the impact of securities issuance when assessing real returns. Trend analysis reveals hidden write-offs and reporting anomalies. Study the fundamental EPS TTM metric to detect hidden declines in profitability.

Direct competitors

HLN: Net earnings per share for the last 12 months|kenvue.com - Earnings per share for the last four quarters|VRNA: Net earnings per share (EPS TTM)|Jyong Biotech Limited - Earnings per share for the trailing year|LGND (Ligand Pharma) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Amneal Corp AMRX|Earnings per share for the last twelve months Perrigo Company plc (PRGO)|ALVO (alvotech.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months Liquidia LQDA|Galapagos N.V. - Earnings per share for the last twelve months|ANI Pharma - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Afrezza|AMPH (Amphastar Pharmaceuticals) - Net earnings per share for the last 12 months|Earnings per share for the last 12 months PCRX|SPRY (ARS Pharmaceuticals, Inc.) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Theravance Biopharma Inc|Earnings per share for the last twelve months Aquestive Pharma (AQST)|SCPH (scpharmaceuticals.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) TECX (Tectonic Therapeutic)|Net earnings per share for the last four quarters tonixpharma.com (TNXP)|SXT China - Net earnings per share (EPS TTM)|EPRX - Net earnings per share (EPS TTM)|BHST (BioHarvest) - Net earnings per share for the last 12 months|Invizyne - Earnings per share for the trailing year|ORMP (Oramed) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months ENTX|Net earnings per share (EPS TTM) HYFT|Net earnings per share for the last four quarters ABVC BioPharma Inc.|Earnings per share for the last twelve months Cumberland Pharma CPIX|Quantum BioPharma Corp (QNTM) - Net earnings per one share for the last twelve months|FGEN - Earnings per share for the last twelve months|Net earnings per share for the last four quarters telomirpharma.com TELO|RANI: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Synergy CHC|RLYB (Rallybio Corp) - Net earnings per share (EPS TTM)|Pulmatrix Corporation (PULM) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) PTHL|APM - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Lyra Therapeutics LYRA|IBO: Earnings per share for the last 12 months|TNF Pharma - Net earnings per share (EPS TTM)|cbdMD, Inc. (YCBD) - Net earnings per share for the last 12 months|PRFX: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Altamira Therapeutics Ltd. (CYTO)|Earnings per share for the last twelve months Lipella Pharmaceuticals, Inc.|Earnings per share for the last twelve months OPTN|Net earnings per share (EPS TTM) PIRS|PROC - Net earnings per one share for the last twelve months|Petros Pharmaceuticals - Net earnings per share for the last 12 months|QLI: Earnings per share for the last 12 months|SLRN: Net earnings per share for the last 12 months|TFFP (TFF Pharmaceuticals Inc.) - Earnings per share for the last 12 months